These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

450 related articles for article (PubMed ID: 6104720)

  • 1. A common mechanism for lysergic acid, indolealkylamine and phenethylamine hallucinogens: serotonergic medication of behavioral effects in rats.
    Sloviter RS; Drust EG; Damiano BP; Connor JD
    J Pharmacol Exp Ther; 1980 Aug; 214(2):231-8. PubMed ID: 6104720
    [No Abstract]   [Full Text] [Related]  

  • 2. Indolealkylamine and phenalkylamine hallucinogens: a brief overview.
    Glennon RA; Rosecrans JA
    Neurosci Biobehav Rev; 1982; 6(4):489-97. PubMed ID: 6757811
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stimulus properties of phenethylamine hallucinogens and lysergic acid diethylamide: the role of 5-hydroxytryptamine.
    Winter JC
    J Pharmacol Exp Ther; 1978 Feb; 204(2):416-23. PubMed ID: 621672
    [No Abstract]   [Full Text] [Related]  

  • 4. Behavioral evidence for the stimulation of CNS serotonin receptors by high doses of LSD.
    Trulson ME; Ross CA; Jacobs BL
    Psychopharmacol Commun; 1976; 2(2):149-64. PubMed ID: 136010
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An electrophysiological analysis of hallucinogens.
    Cowen MA; Nishi H; Hammack D
    Biol Psychiatry; 1973 Dec; 5(3):239-56. PubMed ID: 4708679
    [No Abstract]   [Full Text] [Related]  

  • 6. The behavioral pharmacology of hallucinogens.
    Fantegrossi WE; Murnane KS; Reissig CJ
    Biochem Pharmacol; 2008 Jan; 75(1):17-33. PubMed ID: 17977517
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hallucinogens as discriminative stimuli in animals: LSD, phenethylamines, and tryptamines.
    Winter JC
    Psychopharmacology (Berl); 2009 Apr; 203(2):251-63. PubMed ID: 18979087
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structure-activity-relationships of certain hallucinogenic substances based on brain levels.
    Vogel WH; Evans BD
    Life Sci; 1977 May; 20(10):1629-35. PubMed ID: 69244
    [No Abstract]   [Full Text] [Related]  

  • 9. Some effects of the hallucinogenic drug 2,5-dimethoxy-4-methylamphetamine on the metabolism of biogenic amines in the rat brain.
    Leonard BE
    Br J Pharmacol; 1972 May; 45(1):165P-166P. PubMed ID: 5041482
    [No Abstract]   [Full Text] [Related]  

  • 10. Antagonism of beta-phenylethylamine derivatives and serotonin blocking drugs upon serotonin, tryptamine and reserpine behavioral depression in mice.
    Saavedra JM; Fischer E
    Arzneimittelforschung; 1970 Jul; 20(7):952-7. PubMed ID: 5536068
    [No Abstract]   [Full Text] [Related]  

  • 11. Actions of serotonin and related substances on single neurons in the brain.
    Bradley PB; Briggs I
    Adv Biochem Psychopharmacol; 1974; 10():159-66. PubMed ID: 4527120
    [No Abstract]   [Full Text] [Related]  

  • 12. Hallucinogens as discriminative stimuli.
    Winter JC
    Fed Proc; 1974 Jul; 33(7):1825-32. PubMed ID: 4209212
    [No Abstract]   [Full Text] [Related]  

  • 13. 5-Methoxytryptamine: stimulation of 5-HT receptors mediating the rat hyperactivity syndrome and blood platelet aggregation.
    Boullin DJ; Green AR
    Adv Biochem Psychopharmacol; 1976; 15():127-40. PubMed ID: 15408
    [No Abstract]   [Full Text] [Related]  

  • 14. QSAR of agents involved in serotonin and LSD binding sites.
    Chan YL; Lien EJ; Shih JC
    NIDA Res Monogr; 1978; (22):103-13. PubMed ID: 30904
    [No Abstract]   [Full Text] [Related]  

  • 15. Displacement of specific serotonin and lysergic acid diethylamide binding by Ergalgin, a new antiserotonin drug.
    Oelszner W
    Acta Biol Med Ger; 1980; 39(8-9):897-901. PubMed ID: 7282219
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Action of psychotogenic drugs on single midbrain raphe neurons.
    Aghajanian GK; Foote WE; Sheard MH
    J Pharmacol Exp Ther; 1970 Feb; 171(2):178-87. PubMed ID: 5459056
    [No Abstract]   [Full Text] [Related]  

  • 17. Behavioral and biochemical evidence for a nonessential 5-HT2A component of the ibogaine-induced discriminative stimulus.
    Helsley S; Fiorella D; Rabin RA; Winter JC
    Pharmacol Biochem Behav; 1998 Feb; 59(2):419-25. PubMed ID: 9476990
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Some behavioral effects of hallucinogens are mediated by a postsynaptic serotonergic action: evidence from single unit studies in freely moving cats.
    Heym J; Rasmussen K; Jacobs BL
    Eur J Pharmacol; 1984 May; 101(1-2):57-68. PubMed ID: 6745319
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dihydrobenzofuran analogues of hallucinogens. 4. Mescaline derivatives.
    Monte AP; Waldman SR; Marona-Lewicka D; Wainscott DB; Nelson DL; Sanders-Bush E; Nichols DE
    J Med Chem; 1997 Sep; 40(19):2997-3008. PubMed ID: 9301661
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Failure of N,N-dimethyltryptamine to evoke tolerance in cats.
    Gillin JC; Cannon E; Magyar R; Schwartz M; Wyatt RJ
    Biol Psychiatry; 1973 Dec; 7(3):213-20. PubMed ID: 4519415
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 23.